Objective: Subglottic stenosis remains a clinical challenge. The aim of this study was to evaluate the effect of human adipose tissue-derived mesenchymal stem cells (hAMSCs) in rat model of subglottic stenosis. Subjects and Methods: Ninety-six 13-week-old male rats were enrolled in this study. They were divided into 3 groups as normal control (NC) group, a subglottic injury and media injection (SM) group, and a subglottic injury and media-stem cell injection (SMSC) group. The hAMSCs were immediately injected into subglottis after injury. Histologic characteristics of subglottis; the mRNA expressions of interleukin-1β, cyclooxygenase-2, tumor growth factor-β and basic fibroblast growth factor; and hAMSCs' survival were evaluated. Results: The hAMSCs survived in the subglottis of the rat until 10 days after implantation. The NC and SMSC groups had a significantly wider subglottic lumen and thinner lamina propria than the SM group at 56 days after injury. Collagen intensity of subglottis was significantly higher in the SM group than in the NC and SMSC groups at 28 days after injury. Gene expression didn't show significant difference between the SM group and the SMSC group. Conclusions: The hAMSCs injection was found to be helpful for preventing subglottic stenosis in a rat model.
Introduction
Subglottic stenosis is a critical airway problem. Stenosis typically results from some trauma to the subglottic area such as prolonged endotracheal intubation, long-term tracheotomy, or other traumatic events and may lead to hypertrophic scar formation and narrowing of airway lumen. 1, 2 Treating subglottic stenosis remains a clinical challenge, and the main treatment option is endoscopic dilation with steroid or mitomycin administration. However, these options are applicable only at the early stage of subglottic stenosis and are not effective in treatment of circumferential lesions greater than 1 cm in length. 3 Furthermore, the surgical treatment of subglottic stenosis by resection and reconstruction is commonly complicated by functional sequelae of the larynx.
Adult stem cells can self-replicate and differentiate into many cell types, but they also have paracrine effects, which include anti-inflammatory and angiogenic effects. Mesenchymal stem cells have the ability to block innate immune cells, such as T cells and macrophages, to activate fibroblasts to stimulate reepithelization 4 and have been suggested to modulate wound healing, which is controlled by epithelial and innate immune cell-derived cytokines, such as interleukin-1 and tumor necrotic factor (TNF) and adaptive immune response (T H and B cells). 5 Adipose tissue-derived mesenchymal stem cells (AMSCs) are an attractive option for cell-based wound therapies because of their accessibility and ease of harvesting. The AMSCs transport gene regulatory information and modulate angiogenesis and adipogenesis, 6 and previous studies have shown seeding with AMSCs can improve wound healing by modulating the recruitment and/or functionality of endogenous progenitor cells. 7 It has been shown stem cell-based, tissue-engineered tracheal replacement is a feasible option in animal models. [8] [9] [10] In addition, clinical trials on the reconstruction of long segmenttracheal defects using autologous stem cells and tailored scaffolds have produced satisfactory results allowing normal airway function. 11, 12 However, almost all laboratory and clinical trials have focused on tracheal stenosis and not subglottic stenosis. We hypothesized that stem cell treatment might prevent scar contracture after subglottic mucosal injury, and thus, the aim of this study was to evaluate the effect of human adipose tissue-derived mesenchymal stem cells (hAMSCs) on mucosal wound healing in a rat model of subglottic stenosis.
Materials and Methods

Cell Culture
The hAMSCs (Life Technologies, Carlsbad, California, USA) were grown in MesenPRO RS medium (Thermo Fisher Scientific, Waltham, Massachusetts, USA) in 5% CO 2 humidified incubator at 37°C. The cell suspension was pipetted up and down gently, and 10 μl of the cell suspension was loaded into the 2 hemocytometer chambers. The loaded hemocytometer was then placed on microscope stage, and the cells were counted in the 4-square counting grid. The cell number was calculated using the following formula: (Total cells/ml = Total cells counted × dilution factor/number of squares × 10 000 cells/ml).
Subglottic Stenosis and hAMSCs Injection
Ninety-six male Sprague-Dawley rats (13 week old) were enrolled in this study and were maintained in a temperature-controlled room with access to food and water ad libitum. Twenty-one of them were used to study how long the injected hAMSCs survived in the injured subglottis. The hAMSCs were injected into the submucosa of subglottis through the critotracheal opening. Twenty-one rats were divided into 5 groups, and 4 rats were included in each group. The other 1 was used as a control ( Figure  1A ). According to euthanization days, each of 5 groups was euthanized on 1, 3, 5, 7, and 10 days after hAMSCs injection.
Thirty rats were used to be assessed for subglottic lumen size and collagen distribution by histologic analysis. They were divided into 3 groups as normal control (NC) group, subglottic injury and media injection (SM) group as a sham control group, subglottic injury and mediastem cell injection (SMSC) group as an experimental group. Each group included 10 rats, and it was divided into 2 subgroups according to euthanasia dates, 28 days and 56 days after injury. Each subgroup included 5 rats ( Figure 1B) .
Forty-five rats were used to evaluate inflammatory factor using real-time polymerase chain reaction (RT-PCR) in this study. Forty-two rats were divided into 2 groups as SM group and SMSC groups; each of the groups included 21 rats. Each was group divided into 7 subgroups according to euthanasia dates, 1 day, 3 days, 5 days, 7 days, 10 days, 28 days, and 56 days after injury. Each subgroup included 3 rats. The remaining 3 rats were used as controls ( Figure 1C ).
All experiments were approved by the Institutional Review Border of the Lee Gil Ya Cancer and Diabetes Institute of Gachon University (approval No. LCDI-2013-0014). Animals were anesthetized intraperitoneally (i.p.) with Zoletil (25 mg/kg) and Rompun (5-10 mg/kg). The subglottic stenosis model was produced by electrocauterization of subglottic mucosa, as previously described. 13 Briefly, cricoid and tracheal cartilage were exposed by making a median vertical skin incision on the neck. The cricotracheal membrane was then divided and the subglottic lumen exposed. The anterior subglottic mucosa was damaged by a monopolar electrocauterization, and the power output was 25 watts. The hAMSCs (1 × 10 5 cells) mixed with 10 μl of medium provided in commercial kit (StemPro, Invitrogen, Carlsbad, California, USA) were then injected into submucosal layer beside inflicted mucosa using a Hamilton syringe.
Immunofluorescence Staining
Immunofluorescence (IF) was used to evaluate survival of injected hAMSCs. After antigen retrieval using a sodium citrate solution (ph 7.2), tissue sections of harvested subglottis were incubated in a blocking solution containing normal horse serum to block nonspecific binding. Tissues were incubated with CD44 and human-nuclei (HuNu) antibodies (Abcam, Cambridge, Massachusetts, USA) overnight at 4°C, rinsed with PBS, incubated with 488-fluorescence conjugated secondary antibodies for 1 hour at room temperature, and rewashed with PBS. Nuclei were counterstained using 4', 6-diamidino-2-phenylindole (DAPI, SigmaAldrich, St Louis, Missouri, USA) at room temperature for 1 minute. Fluorescence was detected by a confocal microscopy (LSM 710, Carl Zeiss, Oberkochen, Germany), and intensities were measured using Zeiss Zen 2012 software (Carl Zeiss).
Histologic Evaluation
Thirty rats were assessed for subglottic lumen size and collagen distribution by histologic analysis. Masson's Trichrome staining was performed using a commercial kit (Sigma-Aldrich) for fibrosis analysis. To fix subglottic 4 μm thickness cross-section tissues, slides were placed in Bouin's solution (Sigma-Aldrich) for 15 minutes at 56°C. Tissues were then stained with an iron hematoxylin solution (Merck, Kenilworth, New Jersey, USA) for 5 minutes to observe nuclei, with Biebrich Scarlet solution (SigmaAldrich) for 2 minutes to stain acidophilic tissue components, and then with phosphomolybdic-phosphotungstic acid solution (Sigma-Aldrich) to differentiate tissues; washed with running water; and stained with aniline blue solution (Sigma-Aldrich). Stained tissue slides were then immersed in absolute alcohol for 3 minutes and in xylene for 3 minutes, covered with glass using DPX mounting medium (Sigma-Aldrich), and analyzed under a light microscope. Cross-sectional area of subglottis was observed under a light microscope (Bx51, Olympus, Tokyo, Japan), and lumen size of subglottis and thickness of the lamina propria were measured using on-board DP2-BSW software (Olympus). To measure thickness of the lamina propria, a vertical midline of a subglottic section was made first, followed by bilateral 45° lines from the midline, and finally 3 points of thickness were made by 3 lines passing through the lamina propria of anterior half of subglottis. The average of the 3 anterior depths was the thickness of the lamina propria. Collagen intensities of lamina propria of subglottis were quantified using Image J (Softonic, Barcelona, Spain).
Quantitative RT-PCR
Real-time polymerase chain reaction was used to compare the difference of the mRNA expressions of interleukin-1β, cyclooxygenase-2, tumor growth factor-β, and basic fibroblast growth factor between the SM group and SMSC group. Total RNA in harvested subglottic tissues was isolated using Trizol reagent, according to the manufacturer's instructions. Tissues were homogenized using a disposable pestle in 1 ml Trizol reagent (Invitrogen) at 0°C. Homogenized samples were mixed with 0.2 ml chloroform (Amresco, Solon, Ohio, USA) and centrifuged at 12 000 × g for 15 minutes at 4°C. Aqueous phases were then collected and mixed with 0.5 ml absolute isopropanol to precipitate RNA. After centrifugation and washing with 70% ethanol, dried pellets were dissolved in 20 μl of diethyl pyrocarbonate water. After RNA extraction, complementary DNA (cDNA) was synthesized using the PrimeScript first strand cDNA Synthesis Kit (TAKARA, Kusatsu, Japan). Briefly, 100 ng of each cDNA, 5 μl of SYBR Premix (TAKARA), and 0.4 uM of forward and reverse primers (listed in Table 1 ) were mixed, and the mRNA levels of genes of interest were determined using a CFX384 Touch Real-Time PCR Detection System (Bio-Rad, Hercules, California, USA).
Statistical Analysis
GraphPad Prism 6 was used to for comparison of intergroup differences. The Mann-Whitney U test was performed to demonstrate differences, and a P value of less than .05 was considered statistically significant.
Results
Stem Cell Survival
According to the immunofluorescence study, anti-CD44 and anti-HuNu were positive at 10 days after injection of hAMSCs ( Figure 2 ). Anti-CD44 positive cell counts were 5.87 ± 1.35 at 1 day, 2.12 ± 1.03 at 3 days, 1.65 ± 0.31 at 5 days, 0.90 ± 0.72 at 7 days, and 0.88 ± 0.68 at 10 days after injury, and anti-HuNu positive cell counts were 9.54 ± 1.30 at 1 day, 9.38 ± 0.98 at 3 days, 6.11 ± 1.34 at 5 days, 0.65 ± 0.96 at 7 days, and 0.06 ± 0.70 at 10 days after injury. The hAMSCs survived in the subglottis of rat until 10 days after implantation.
Histologic Characters
The H&E staining conducted 28 and 56 days after injury revealed destruction of anterior cricoid cartilage in both SM ( Figures 3C and 3D ) and SMSC groups ( Figures 3E and  3F ), which were inflicted subglottic mucosa by electrocauterization, but not in the NC group ( Figures 3A and 3B) . Thick lamina propria and narrow subglottis lumen were found in the SM group (Figures 3C and 3D) . Figure 2 . Survival of injected human adipose tissue-derived mesenchymal stem cells (hAMSCs. In immunofluorescence study, anti-CD44 and anti-HuNu were positive in rat's subglottis at 10 days after injury.
At 28 days after injury, no significant difference was found between 3 groups of lumen size, but at 56 days after injury, the SM group showed significantly narrower subglottis lumen than the SMSC or NC groups (P = .0079 for NC vs SM and P = .0317 for SMSC vs SM) ( Figure 3G , Table 2 ). When we performed intragroup comparisons at 28 and 56 days after injury, subglottis lumen were wider at 56 than at 28 days after injury in the NC group (P = .0317) but were narrower at 56 days in the SM group (P = .0410) and no different in the SMSC group (P = .9108) ( Figure 3G , Table 2 ).
At 28 days after injury, no significant difference was found between 3 groups of lamina propria thickness, but at 56 days after injury, the SM group showed (G) Subglottic lumen was significantly narrower in SM group than in other 2 groups at 56 days after injury and significantly changed between days 28 and 56 in NC and SM groups. (H) Lamina proproa was significantly thicker in SM group than in other 2 groups at 56 days after injury. significantly thicker lamina propria than the SMSC or NC groups (P = .0208 for NC vs SM and P = .0164 for SMSC vs SM) ( Figure 3H , Table 2 ). In intragroup comparisons at 28 and 56 days after injury, thickness of lamina propria didn't have any significant difference ( Figure 3H , Table 2 ).
Masson trichrome staining was used to evaluate fibrosis of lamina propria. A 28 days after injury, SM group showed blue collagen bundles in entire area of lamina propria ( Figure 4C ), but SMSC groups showed blue collagen bundle in partial area of lamina propria ( Figure 4E ). Collagen intensity was higher in the SM group than in the NC group (P = .0290) and SMSC group (P = .0451) ( Figure 4G , Table 2 ). At 56 days after injury, the SM group ( Figure 4D ) had higher collagen intensity than the NC group ( Figure 4B ) (P = .0060), but there was no significant difference between the SM group and SMSC group ( Figure 4F ) about collagen intensities ( Figure 4G , Table 2 ). When collagen intensities were compared at days 28 and 56 in each group, the SM and SMSC groups were found to have a higher collagen intensity on day 56 than on day 28 (P = .0418 and .0423, respectively) ( Figure 4G , Table 2 ).
RT-PCR
No significant differences were found between the SM and SMSC group about mRNA levels of IL1β, TGFβ, COX2, and bFGF ( Figure 5 ).
Discussion
In the present study, we sought to determine whether human adipose tissue-derived mesenchymal stem cells might prevent subglottic stenosis in a rat model. We found that the SMSC group showed less fibrosis of subglottis than the SM group at 28 days after injury. Also, the SMSC group had wider subglottic lumen than the SM group at 56 days after injury. The change of lamina propria thickness was inversely proportional with the change of subglottic lumen, as we hypothesized. The SM group had thicker lamina propria than the SMSC group at 56 days after injury. These results suggest that injected hAMSCs might delay fibrosis in subglottis and subsequently prevent subglottic stenosis at 56 days after injury.
Interesting results were found when intragroup comparison between 28 days and 56 days in each of the 3 groups was done. About the size of subglottic lumen, the NC group showed a wider subglottic lumen at 56 days than the 28th day after injury, which is considered to be due to the normal growth of rats. The SM group was found to have narrower subglottic lumen at 56 days than at 28 days after injury. This means that the subglottic stenosis gradually deteriorated between 28 and 56 days after injury. The SMSC group showed no difference in the size of the subglottic lumen on the 28th and 56th days after the injury, indicating that the injected hAMSCs did not normalize the injured organ but prevented stenosis by day 56. About the thickness of subglottic lamina propria, in the NC group, there was no difference in the thickness of the lamina propria on days 28 and 56 after injury. This suggests that the lamina propria is independent of the growth of the rat. Though there was no statistical significance, the SM group and the SMSC group showed a thicker lamina propria on the 28th day after injury than the normal control group. This may be due to the edema of the damaged mucosa and the volume of the injected material. On the 56th day after the injury, the SM group and the SMSC group showed mutually different changes with respect to the thickness of the lamina propria. Although there was no statistical significance, the SM group was found to be thicker on the 56th day than on the 28th day, while the SMSC group became thinner. These results suggest that stem cells inhibit the fibrosis of the damaged subglottis and consequently prevent subglottic stenosis by 56 days.
It should be noted that there was a significant difference between SM group and SMSC group about collagen intensity at 28 days after injury, but there was no significant difference between groups at 56 days after injury. Such a result implies that the injected hAMSCs did not prevent fibrosis in the damaged subglottis but only delayed it. This study observed changes in subglottis up to 56 days after injury, so there is a limit to investigating the effects of injected stem cells over a long period of time.
Unfortunately, this study failed to reveal molecular mechanism of hAMSCs preventing stenosis in injured subglottis of rat. However, it was sufficient to show phenotypic effect of hAMSCs. Further animal study was mandatory to reveal the molecular mechanism.
Recently, xenogenic stem cell implantation was explored in several studies. Jia et al 14 reported rat AMSCs could resist human natural antibody and complement-mediated cytotoxicity when incubated with 20% or 50% normal human serum in vitro, and Chen et al 15 reported xenogenic AMSCs therapy could reduce brain-infarct volumes and enhance neurological recovery in rats after acute ischemic stroke. However, there is little research on whether xenogenic stem cell implantation can prevent fibrosis of damaged airways. This study was the first animal study to examine the effect of xenogenic stem cell implantation on subglottic stenosis. This experiment showed that implantation of hAMSC helped to prevent subglottic stenosis in rat by day 56 after injury there was.
Conclusion
The hAMSCs survived in the subglottis of rat until 10 days after implantation. The SMSC group exhibited minimal fibrosis at 28 days after injury and showed less subglottic stenosis at 56 days after injury than the SM group. This finding suggests injected hAMSCs inhibited subglottic stenosis in our rat model. A further study is needed to confirm the long-term preventive effects of hAMSCs and the mechanism responsible for their beneficial effects. Gene expressions of inflammatory factors. No significant differences were found between the subglottic injury and media injection (SM) and subglottic injury and media-stem cell injection (SMSC) groups for mRNA levels of IL1β, TGFβ, COX2, and bFGF.
